γH2AX can be a biomarker to distinguish between benign and malignant lesions in bile duct biopsy specimens

Authors :: Hitoshi Kameyama
Toshifumi Wakai
Yoshifumi Shimada
Kizuki Yuza
Masayuki Nagahashi
Hiroshi Ichikawa
Kohei Miura
Takashi Kobayashi
Jun Sakata
Yuki Hirose
Source :: HPB. 21:S325-S326
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pathology
medicine.medical_specialty
medicine.anatomical_structure
Hepatology
medicine.diagnostic_test
business.industry
Bile duct
Biopsy
Gastroenterology
Medicine
Biomarker (medicine)
business

Full Text Access

Tools